This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Janssen Alzheimer Immunotherapy, Wyeth. Active years: 2011.
Company Filing History:
1 out of 23 
1 out of 1,309 
Years Active: 2011
Title: The Innovative Contributions of Sally Schroeter
Introduction
Sally Schroeter is a notable inventor based in Belmont, California. She has made significant contributions to the field of medical research, particularly in the treatment of cerebral amyloid angiopathy (CAA). Her work has implications for patients suffering from both CAA and Alzheimer's disease.
Latest Patents
Sally Schroeter holds a patent for her invention titled "Treatment of cerebral amyloid angiopathy." This invention provides improved agents and methods for treating CAA and offers methods for prophylaxis of the condition. The methods can treat CAA concurrently with Alzheimer's disease or separately. They involve administering an antibody that is specific for the N-terminus of Aβ or an agent that can induce such an antibody. This innovative approach has the potential to significantly impact treatment options for affected patients.
Career Highlights
Throughout her career, Sally has worked with prominent companies in the pharmaceutical industry, including Janssen Alzheimer Immunotherapy and Wyeth. Her experience in these organizations has allowed her to develop her expertise in the field of Alzheimer's research and treatment.
Collaborations
Sally has collaborated with notable colleagues, including Kate Dora Games and Wagner Marcelo Zago. These partnerships have contributed to her innovative research and the development of her patented methods.
Conclusion
Sally Schroeter's contributions to the treatment of cerebral amyloid angiopathy highlight her role as a leading inventor in the medical field. Her innovative methods and collaborations continue to pave the way for advancements in Alzheimer's disease treatment.